Managers / Q2 2020 · view latest →
EXANE DERIVATIVES
CIK 0001623883 · 6 RUE MENARS, PARIS, I0, 75002 · 33 1 44 95 40 00
Reported Value
$374.2B
Q2 2020
Positions
687
Filings on Record
16
2019–present window
Filed
Jul 10, 2020
original filing
Summary
Exane Derivatives reported $374.2B in U.S.-listed holdings across 687 positions for Q2 2020.
Compared with Q1 2020, the fund opened 61 new positions and exited 75.
Reported Value by Quarter
13F Reported Value
Portfolio Composition
By security type
Composition data arrives with ticker enrichment.
Quarter-over-Quarter Changes full breakdown →
Holdings — Q2 2020
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q2 2022 | $174.0B | 758 | Jul 12, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $355.1B | 1,021 | Apr 22, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $413.3B | 890 | Jan 28, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $416.5B | 1,046 | Oct 26, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $441.0B | 1,054 | Jul 28, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $349.8B | 894 | Apr 30, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $340.0B | 838 | Jan 27, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $345.3B | 754 | Oct 8, 2020 | RESTATEMENT | changes · EDGAR ↗ |
| Q2 2020 | $374.2B | 687 | Jul 10, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $357.9B | 702 | Apr 17, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $539.7B | 684 | Jan 22, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $557.6B | 654 | Oct 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $570.5B | 668 | Jul 12, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $505.8B | 637 | Apr 24, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $557.3B | 674 | Jan 31, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.